CRIS Current Research Information System

BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.410
EU - Europa 22.362
AS - Asia 15.742
AF - Africa 1.162
SA - Sud America 1.048
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 17
Totale 64.769
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.223
IT - Italia 7.761
SG - Singapore 4.805
GB - Regno Unito 4.383
CN - Cina 4.225
VN - Vietnam 3.385
DE - Germania 2.166
SE - Svezia 2.162
HK - Hong Kong 1.376
UA - Ucraina 1.100
RU - Federazione Russa 964
IN - India 945
FR - Francia 875
BR - Brasile 737
IE - Irlanda 674
NL - Olanda 539
CH - Svizzera 412
TG - Togo 374
ZA - Sudafrica 366
EE - Estonia 331
JP - Giappone 237
JO - Giordania 223
FI - Finlandia 222
CI - Costa d'Avorio 219
BG - Bulgaria 217
KR - Corea 148
AR - Argentina 137
CA - Canada 103
IR - Iran 102
SC - Seychelles 102
BE - Belgio 100
AT - Austria 84
GR - Grecia 80
ES - Italia 68
PL - Polonia 62
EC - Ecuador 58
MX - Messico 56
ID - Indonesia 46
NG - Nigeria 42
TR - Turchia 38
BD - Bangladesh 35
CL - Cile 30
LB - Libano 27
CO - Colombia 26
UZ - Uzbekistan 26
HR - Croazia 25
MY - Malesia 24
RO - Romania 23
AU - Australia 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
LT - Lituania 18
PE - Perù 18
PY - Paraguay 17
PT - Portogallo 15
IL - Israele 14
VE - Venezuela 12
AL - Albania 11
EG - Egitto 11
MA - Marocco 11
PK - Pakistan 11
PH - Filippine 10
EU - Europa 9
TN - Tunisia 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
NZ - Nuova Zelanda 6
DK - Danimarca 5
DZ - Algeria 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
SM - San Marino 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
KE - Kenya 4
KZ - Kazakistan 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
RS - Serbia 4
SA - Arabia Saudita 4
UG - Uganda 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
PA - Panama 3
SN - Senegal 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CG - Congo 2
CU - Cuba 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
MK - Macedonia 2
Totale 64.732
Salva come PNG Salva come JPEG
Città #
Southend 3.832
Singapore 3.089
Fairfield 2.728
Ashburn 2.387
Chandler 2.123
Dong Ket 1.542
Hong Kong 1.363
Woodbridge 1.361
Wilmington 1.177
Houston 1.161
Seattle 1.158
Santa Clara 1.135
Cambridge 984
Princeton 937
Ann Arbor 875
Dublin 665
Jacksonville 655
Boardman 590
Beijing 565
Rome 554
Hefei 520
Milan 507
Bologna 476
Padova 422
Nanjing 409
Ho Chi Minh City 399
Westminster 398
Lomé 374
Bern 330
Hanoi 317
Los Angeles 291
Berlin 273
Tokyo 229
Dallas 224
Amman 223
Abidjan 219
Sofia 215
Jinan 207
Saint Petersburg 198
Shenyang 197
Buffalo 196
Verona 192
Turin 180
Helsinki 179
San Diego 178
Florence 176
Palermo 166
New York 163
Changsha 145
Seoul 137
Medford 133
Naples 132
Hebei 131
Mülheim 129
Munich 125
Nanchang 123
Redondo Beach 117
Tianjin 100
Dearborn 94
Frankfurt am Main 94
Brussels 93
Bari 90
Redmond 88
Guangzhou 82
São Paulo 81
Des Moines 79
Zhengzhou 79
Shanghai 78
Redwood City 76
Mahé 74
Bremen 70
London 67
Jiaxing 66
Norwalk 63
Ningbo 61
Falkenstein 60
Chicago 59
Catania 52
Genoa 52
Paris 52
Hangzhou 51
Bengaluru 49
Olalla 49
Mountain View 48
Haikou 45
Lanzhou 44
Phoenix 44
Toronto 44
Wuhan 44
Yubileyny 43
Abeokuta 41
Falls Church 40
Nuremberg 40
Haiphong 39
Amsterdam 38
Kunming 38
Ardabil 37
Düsseldorf 37
Napoli 36
Parma 36
Totale 40.464
Salva come PNG Salva come JPEG
Nome #
La cardiomiopatia cirrotica. 2.582
L’ipotesi unificante sulla regolazione del volume dei fluidi corporei. Fisiologia e fisiopatologia dell’omeostasi idrosalina, con particolare riguardo allo scompenso cardiaco e alla cirrosi epatica. 1.882
Cirrosi epatica e sue complicanze 741
L’arterializzazione della vena porta per insuffcienza epatica acuta 658
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 386
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 375
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 308
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 284
L’albumina nelle malattie del fegato. 283
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 260
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 259
Hyponatremia in patients with cirrhosis of the liver 255
g-hydroxybutyrate as a treatment for alcoholism. 246
Patologie alcol-relate e trattamento dell’alcolismo. 242
Alcol, sindrome feto-alcolica, apparato ematopoietico, muscolo-scheletrico, respiratorio, cute e reni. 237
Adaptive response in Hepatitis B virus infection 232
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 229
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 227
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection. 226
Mutations in the E2-PEPHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma. 222
L’ipotesi unificante sulla regolazione del volume dei fluidi corporei. Fisiologia e fisiopatoloiga dell’omeostasi idrosalina, con particolare riguardo allo scompenso cardiaco e alla cirrosi epatica. 219
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 218
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 218
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 213
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 213
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 212
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 209
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation. 208
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 208
A novel model of CCl4-induced cirrosi with ascites in the mouse. 207
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 204
Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. 203
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 203
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 203
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 202
Alcohol and viral hepatitis: a mini-review. 202
Acute alcohol intoxication. 201
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 201
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 200
Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. 199
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 198
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 198
Art in hospital: its impact on the feelings and emotional state of patients admitted to an Internal Medicine Unit. 196
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 196
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 195
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 194
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 194
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 192
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 191
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 188
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 185
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 185
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 183
L’iponatremia nel paziente con cirrosi epatica. 183
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 181
Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. 181
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 180
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 180
Duodenal histology in patients with celiac disease after a gluten-free diet 179
Cardiac electrophysiological abnormalities in patients with cirrhosis. 179
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 179
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 179
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 179
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 178
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 178
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 178
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 178
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 178
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 178
Assorbimento e metabolismo dell’etanolo. 176
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 175
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 174
Clinical indications for the albumin use: Still a controversial issue. 174
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 174
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 174
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 173
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 173
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 172
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 171
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 171
Recent advances in the natural history of hepatocellular carcinoma. 171
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 171
Gamma-hydroxybutyric acid plus naltrexone in the treatment of alcoholics resistant to monotherapy. 170
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 170
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned. 170
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 169
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 169
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 169
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 169
Insufficienza epatica acuta ed epatite subacuta. 167
Vitamins in the treatment of chronic viral hepatitis. 167
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 166
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 166
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 166
Gamma hydroxybutirric acid (GHB) withdrawal does not occur at therapeutic dosage. 165
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 165
null 164
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 164
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 164
Predicting the development of hepatocellular cancer in hepatitis B carriers. 163
Totale 24.892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.662 0 0 0 0 0 326 167 397 576 379 406 2.411
2021/20229.160 881 414 551 780 764 492 306 572 351 549 2.106 1.394
2022/20239.778 968 1.374 494 1.169 571 766 362 545 1.609 347 835 738
2023/20243.737 257 502 241 336 306 560 245 328 168 285 239 270
2024/202510.323 444 1.696 885 875 1.796 530 619 338 221 681 288 1.950
2025/20269.554 1.510 1.668 1.926 1.456 2.348 646 0 0 0 0 0 0
Totale 65.681